Grail has partnered with Epic to broaden ordering access for its Galleri multi-cancer early detection test inside electronic health record workflows. The collaboration enables clinicians using Epic to order Galleri within native EHR environments and receive results through existing clinical and patient portal channels. Grail said the integration planning began in Q1 2026, with broader availability targeted for the end of 2026. The company noted that the deal is designed to reduce operational barriers and support earlier detection before symptoms appear. The initiative follows similar distribution steps, including prior integration with athenahealth and Galleri adding to Quest Diagnostics blood-test offerings. Terms were not disclosed, but the operational scope—about 450 health systems—signals a push from lab access into real-world ordering workflows. The clinical impact will depend on uptake by health systems and consistency of follow-up pathways once results are returned through EHR-based systems.